Decision Diagnostics Stock Analysis
| DECN Stock | USD 0.0001 0.00 0.00% |
Decision Diagnostics is overvalued with Real Value of 8.4E-5 and Hype Value of 1.0E-4. The main objective of Decision Diagnostics stock analysis is to determine its intrinsic value, which is an estimate of what Decision Diagnostics is worth, separate from its market price. There are two main types of Decision Diagnostics' stock analysis: fundamental analysis and technical analysis. Fundamental analysis focuses on the financial and economic factors that affect Decision Diagnostics' performance, such as revenue growth, earnings, and financial stability. Technical analysis, on the other hand, focuses on the price and volume data of Decision Diagnostics' stock to identify patterns and trends that may indicate its future price movements.
The Decision Diagnostics stock is traded in the USA on OTCCE Exchange, with the market opening at 09:30:00 and closing at 16:00:00 every Mon,Tue,Wed,Thu,Fri except for officially observed holidays in the USA. Decision Diagnostics is usually not traded on Thanksgiving Day, Christmas Day, New Year 's Day, Dr . Martin Luther King Jr 's Birthday, Washington 's Birthday, Good Friday, Memorial Day, Juneteenth Holiday, Independence Day, Labour Day. Decision Stock trading window is adjusted to America/New York timezone. Here, you can get updates on important government artifacts, including earning estimates, SEC corporate filings, announcements, and Decision Diagnostics' ongoing operational relationships across important fundamental and technical indicators.
Decision |
Decision Stock Analysis Notes
The company recorded a loss per share of 0.02. Decision Diagnostics had not issued any dividends in recent years. The entity had 1.1:1 split on the 28th of December 2011. Decision Diagnostics Corp. develops smart phone based electronic medical record technologies. Decision Diagnostics Corp. was founded in 2000 and is based in Westlake Village, California. Decision Diagnostics operates under Pharmaceutical Retailers classification in the United States and is traded on OTC Exchange. It employs 6 people. To learn more about Decision Diagnostics call Keith Berman at 805 446 1973 or check out https://www.decisiondiagnostics.co.Decision Diagnostics Investment Alerts
Many investors view ongoing market volatility as an opportunity to purchase more stocks at a favorable price or short it to generate a bearish trend profit opportunity. If you are one of those investors, make sure you clearly understand the position you are entering. Decision Diagnostics' investment alerts are automatically generated signals that are significant enough to either complement your investing judgment regarding Decision Diagnostics or challenge it. These alerts can help you understand what you are buying and avoid costly mistakes.
| Decision Diagnostics generated a negative expected return over the last 90 days | |
| Decision Diagnostics has some characteristics of a very speculative penny stock | |
| Decision Diagnostics has a very high chance of going through financial distress in the upcoming years | |
| The company currently holds 2.93 M in liabilities with Debt to Equity (D/E) ratio of 9.05, indicating the company may have difficulties to generate enough cash to satisfy its financial obligations. Decision Diagnostics has a current ratio of 0.25, indicating that it has a negative working capital and may not be able to pay financial obligations when due. Debt can assist Decision Diagnostics until it has trouble settling it off, either with new capital or with free cash flow. So, Decision Diagnostics' shareholders could walk away with nothing if the company can't fulfill its legal obligations to repay debt. However, a more frequent occurrence is when companies like Decision Diagnostics sell additional shares at bargain prices, diluting existing shareholders. Debt, in this case, can be an excellent and much better tool for Decision to invest in growth at high rates of return. When we think about Decision Diagnostics' use of debt, we should always consider it together with cash and equity. | |
| The entity reported the previous year's revenue of 1.98 M. Net Loss for the year was (29.67 M) with profit before overhead, payroll, taxes, and interest of 194.17 K. | |
| Decision Diagnostics currently holds about 210.85 K in cash with (1.4 M) of positive cash flow from operations. | |
| Decision Diagnostics has a frail financial position based on the latest SEC disclosures | |
| Latest headline from news.google.com: Decision Diagnostics CEO Berman hit with stiff prison sentence - BioWorld Online |
Decision Market Capitalization
The company currently falls under 'Nano-Cap' category with a current market capitalization of 357. Market capitalization usually refers to the total value of a company's stock within the entire market. To calculate Decision Diagnostics's market, we take the total number of its shares issued and multiply it by Decision Diagnostics's current market price. To manage market risk and economic uncertainty, many investors today build portfolios that are diversified across equities with different market capitalizations. However, as a general rule, conservative investors tend to hold large-cap stocks, and those looking for more risk prefer small-cap and mid-cap equities.Decision Profitablity
Decision Diagnostics' profitability indicators refer to fundamental financial ratios that showcase Decision Diagnostics' ability to generate income relative to its revenue or operating costs. If, let's say, Decision Diagnostics is currently losing money, the management's focus should be on how to reverse that trend. However, when revenue exceeds expenses, Decision Diagnostics' executives or investors may be in less hurry to break that information down - which is where profitability analysis comes into play. Gaining a greater understanding of Decision Diagnostics' profitability requires more research than a typical breakdown of Decision Diagnostics' financial statements. By doing a profitability analysis, companies can identify areas needing attention, and investors can make a profitable trade.
| Last Reported | Projected for Next Year | ||
| Return On Tangible Assets | (8.44) | (8.02) | |
| Return On Capital Employed | (2.61) | (2.48) | |
| Return On Assets | (4.72) | (4.49) | |
| Return On Equity | (70.55) | (67.03) |
Management Efficiency
Decision Diagnostics has return on total asset (ROA) of (0.2122) % which means that it has lost $0.2122 on every $100 spent on assets. This is way below average. Similarly, it shows a return on stockholder's equity (ROE) of (81.6052) %, meaning that it created substantial loss on money invested by shareholders. Decision Diagnostics' management efficiency ratios could be used to measure how well Decision Diagnostics manages its routine affairs as well as how well it operates its assets and liabilities. As of the 1st of May 2024, Return On Tangible Assets is likely to grow to -8.02. In addition to that, Return On Capital Employed is likely to grow to -2.48. At this time, Decision Diagnostics' Other Current Assets are very stable compared to the past year. As of the 1st of May 2024, Total Current Assets is likely to grow to about 2.5 M, while Total Assets are likely to drop about 5.2 M.| Last Reported | Projected for Next Year | ||
| Book Value Per Share | 0 | 0 | |
| Net Current Asset Value | 0.00 | 0.00 | |
| Tangible Asset Value | 0.00 | 0.00 | |
| Tangible Book Value Per Share | (0.01) | (0.01) | |
| Enterprise Value Over EBITDA | (3.04) | (3.19) | |
| Price Book Value Ratio | 11.41 | 6.01 | |
| Enterprise Value Multiple | (3.04) | (3.19) | |
| Price Fair Value | 11.41 | 6.01 | |
| Enterprise Value | 6.4 M | 3.7 M |
The analysis of Decision Diagnostics' management efficiency is an essential part of evaluating and assessing the financial and operational performance of the entity. It is also vital to analyze Decision Diagnostics' future growth prospects and the overall market conditions to determine the value and potential of its stock. The analysis involves studying a range of financial metrics such as revenue, earnings, profit margins, cash flow, debt, market share, and external factors such as economic trends, industry outlook, competition, and government regulations. The goal of Decision Stock analysis is to determine whether it is undervalued, fairly valued, or overvalued and to make informed investment decisions.
Beta (1.70) |
Technical Drivers
Decision Diagnostics technical analysis allows you to utilize historical prices and volume patterns in order to determine a pattern that computes the direction of the firm's future prices. Put another way, you can use this information to find out if the firm will indeed mirror its model of historical prices and volume momentum, or the prices will eventually revert. We were able to break down zero technical drivers for Decision Diagnostics, which can be compared to its peers.Decision Diagnostics Price Movement Analysis
The output start index for this execution was twenty-eight with a total number of output elements of thirty-three. The Bollinger Bands is very popular indicator that was developed by John Bollinger. It consist of three lines. Decision Diagnostics middle band is a simple moving average of its typical price. The upper and lower bands are (N) standard deviations above and below the middle band. The bands widen and narrow when the volatility of the price is higher or lower, respectively. The upper and lower bands can also be interpreted as price targets for Decision Diagnostics. When the price bounces off of the lower band and crosses the middle band, then the upper band becomes the price target.
About Decision Stock Analysis
Stock analysis is the technique used by a trader or investor to examine and evaluate how Decision Diagnostics prices is reacting to, or reflecting on a current market direction and economic conditions. It can be used to make informed decisions about market timing, and when buying or selling Decision shares will generate the highest return on investment. We also built our stock analysis module to help investors to gain an insight into the world economy as a whole, the stock market, thematic ideas. a specific sector, or an individual Stock such as Decision Diagnostics. By using and applying Decision Stock analysis, traders can create a robust methodology for identifying Decision entry and exit points for their positions.
| Last Reported | Projected for Next Year | ||
| Pretax Profit Margin | (13.49) | (14.17) | |
| Operating Profit Margin | (0.96) | (1.01) | |
| Net Loss | (13.49) | (14.17) | |
| Gross Profit Margin | 0.23 | 0.14 |
Be your own money manager
As an investor, your ultimate goal is to build wealth. Optimizing your investment portfolio is an essential element in this goal. Using our stock analysis tools, you can find out how much better you can do when adding Decision Diagnostics to your portfolios without increasing risk or reducing expected return.Did you try this?
Run Content Syndication Now
Content SyndicationQuickly integrate customizable finance content to your own investment portal |
| All Next | Launch Module |
Check out Investing Opportunities to better understand how to build diversified portfolios, which includes a position in Decision Diagnostics. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in main economic indicators. To learn how to invest in Decision Stock, please use our How to Invest in Decision Diagnostics guide.Note that the Decision Diagnostics information on this page should be used as a complementary analysis to other Decision Diagnostics' statistical models used to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Balance Of Power module to check stock momentum by analyzing Balance Of Power indicator and other technical ratios.
Complementary Tools for Decision Stock analysis
When running Decision Diagnostics' price analysis, check to measure Decision Diagnostics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Decision Diagnostics is operating at the current time. Most of Decision Diagnostics' value examination focuses on studying past and present price action to predict the probability of Decision Diagnostics' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Decision Diagnostics' price. Additionally, you may evaluate how the addition of Decision Diagnostics to your portfolios can decrease your overall portfolio volatility.
| Bond Analysis Evaluate and analyze corporate bonds as a potential investment for your portfolios. | |
| Pair Correlation Compare performance and examine fundamental relationship between any two equity instruments | |
| Portfolio Suggestion Get suggestions outside of your existing asset allocation including your own model portfolios | |
| CEOs Directory Screen CEOs from public companies around the world | |
| Competition Analyzer Analyze and compare many basic indicators for a group of related or unrelated entities | |
| Portfolio Holdings Check your current holdings and cash postion to detemine if your portfolio needs rebalancing | |
| Risk-Return Analysis View associations between returns expected from investment and the risk you assume | |
| Sync Your Broker Sync your existing holdings, watchlists, positions or portfolios from thousands of online brokerage services, banks, investment account aggregators and robo-advisors. | |
| Theme Ratings Determine theme ratings based on digital equity recommendations. Macroaxis theme ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
| Global Markets Map Get a quick overview of global market snapshot using zoomable world map. Drill down to check world indexes | |
| ETFs Find actively traded Exchange Traded Funds (ETF) from around the world | |
| Technical Analysis Check basic technical indicators and analysis based on most latest market data |
Is Decision Diagnostics' industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Decision Diagnostics. If investors know Decision will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Decision Diagnostics listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (0.02) | Revenue Per Share 0.006 | Quarterly Revenue Growth (0) | Return On Assets (0.21) | Return On Equity (81.61) |
The market value of Decision Diagnostics is measured differently than its book value, which is the value of Decision that is recorded on the company's balance sheet. Investors also form their own opinion of Decision Diagnostics' value that differs from its market value or its book value, called intrinsic value, which is Decision Diagnostics' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Decision Diagnostics' market value can be influenced by many factors that don't directly affect Decision Diagnostics' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Decision Diagnostics' value and its price as these two are different measures arrived at by different means. Investors typically determine if Decision Diagnostics is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Decision Diagnostics' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.